Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Comenzo

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Bone Marrow Transplantation|June 25, 2008
High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition diseaseH Hassoun, C Flombaum, V D D'Agati, et al.
British Journal of Haematology|January 14, 2004
Systemic AL amyloidosis due to non-Hodgkin's lymphoma: an unusual clinicopathologic associationA D Cohen, P Zhou, Q Xiao, et al.
American Journal of Hematology|February 1, 1991
Prompt engraftment using autologous peripheral blood stem cells for double autologous bone marrow rescueC D Hillyer, R L Comenzo, K B Miller, et al.
Leukemia|May 8, 2009
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple MyelomaM Dimopoulos, E Terpos, R L Comenzo, et al.
Bone Marrow Transplantation|December 17, 2003
High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trialV Sanchorawala, D G Wright, D C Seldin, et al.
Blood Cancer Journal|September 18, 2012
Cancer-testis antigen expression and immunogenicity in AL amyloidosisM A Rosenzweig, H Landau, D Seldin, et al.
Blood|June 20, 1998
Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patientsR L Comenzo, E Vosburgh, R H Falk, et al.
Leukemia|April 6, 2012
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosisR L Comenzo, D Reece, G Palladini, et al.
Bone Marrow Transplantation|January 11, 2005
Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trialS Gupta, P Zhou, H Hassoun, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 8, 2000
Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosisN Raje, G Kica, D Chauhan, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|June 25, 2008
High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition diseaseH Hassoun, C Flombaum, V D D'Agati, et al.
British Journal of Haematology|January 14, 2004
Systemic AL amyloidosis due to non-Hodgkin's lymphoma: an unusual clinicopathologic associationA D Cohen, P Zhou, Q Xiao, et al.
American Journal of Hematology|February 1, 1991
Prompt engraftment using autologous peripheral blood stem cells for double autologous bone marrow rescueC D Hillyer, R L Comenzo, K B Miller, et al.
Leukemia|May 8, 2009
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple MyelomaM Dimopoulos, E Terpos, R L Comenzo, et al.
Bone Marrow Transplantation|December 17, 2003
High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trialV Sanchorawala, D G Wright, D C Seldin, et al.
Blood Cancer Journal|September 18, 2012
Cancer-testis antigen expression and immunogenicity in AL amyloidosisM A Rosenzweig, H Landau, D Seldin, et al.
Blood|June 20, 1998
Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patientsR L Comenzo, E Vosburgh, R H Falk, et al.
Leukemia|April 6, 2012
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosisR L Comenzo, D Reece, G Palladini, et al.
Bone Marrow Transplantation|January 11, 2005
Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trialS Gupta, P Zhou, H Hassoun, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 8, 2000
Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosisN Raje, G Kica, D Chauhan, et al.
Pageof 5